🇺🇸 FDA
Patent

US 10485796

LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

granted A61KA61K2039/507A61K31/444

Quick answer

US patent 10485796 (LPT-723 and immune checkpoint inhibitor combinations and methods of treatment) held by Biomed Valley Discoveries, Inc. expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Biomed Valley Discoveries, Inc.
Grant date
Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/507, A61K31/444, A61K39/3955, A61K39/39558